Capricor Therapeutics
CAPR
#6230
Rank
ยฃ0.50 B
Marketcap
ยฃ14.18
Share price
-9.85%
Change (1 day)
507.94%
Change (1 year)

Revenue for Capricor Therapeutics (CAPR)

Revenue in 2024 (TTM): ยฃ21.58 Million

According to Capricor Therapeutics 's latest financial reports the company's current revenue (TTM ) is ยฃ20.81 Million. In 2023 the company made a revenue of ยฃ19.76 Million an increase over the revenue in the year 2022 that were of ยฃ2.1 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Capricor Therapeutics from 2009 to 2024

Annual revenue

Year Revenue Change
2024 (TTM) ยฃ21.58 M9.22%
2023 ยฃ19.76 M837.08%
2022 ยฃ2.1 M1062.45%
2021 ยฃ0.18 M-20.29%
2020 ยฃ0.22 M-70.3%
2019 ยฃ0.76 M-41.79%
2018 ยฃ1.31 M-18.76%
2017 ยฃ1.62 M-37.31%
2016 ยฃ2.58 M1.46%
2015 ยฃ2.54 M-4.79%
2014 ยฃ2.67 M
2013 N/A-100%
2012 ยฃ0.12 M-86.12%
2011 ยฃ0.87 M
2010 N/A
2009 N/A

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
ยฃ2.4 M-88.46%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ3.44 M-83.46%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ66.37 B 318,754.25%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ1.62 B 7,705.99%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ6.36 M-69.42%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ0.12 M-99.40%๐Ÿ‡บ๐Ÿ‡ธ USA